Hedge fund billionaire Bill Ackman will testify before the US Senate on Wednesday and answer questions about his relationship with Valeant Pharmaceuticals. Ackman sits on the board of the embattled company, and is one of its major shareholders. In 2014 he helped Valeant with its failed bid to acquire Allergan Pharmaceuticals.